<?xml version="1.0" encoding="UTF-8" standalone="yes"?><drugRecordOutput id="90206"><DrugName>USP7 inhibitors (cancer), Genentech</DrugName><DrugSynonyms><Name><Value>USP7 inhibitors (cancer), Genentech</Value></Name></DrugSynonyms><CompanyOriginator id="19453">Genentech Inc</CompanyOriginator><CompaniesPrimary><Company id="19453">Genentech Inc</Company></CompaniesPrimary><CrossReferences><SourceEntity id="19453" type="Company"><TargetEntity id="4295912132" type="organizationId">Genentech Inc</TargetEntity></SourceEntity><SourceEntity id="651" type="ciIndication"><TargetEntity id="576" type="siCondition"/></SourceEntity><SourceEntity id="1545" type="Action"><TargetEntity id="4644" type="Mechanism">Anti-PD-L1/ VISTA Immune Checkpoint</TargetEntity><TargetEntity id="1937" type="Mechanism">Anti-Tumor Associated Glycoprotein 72 (TAG-72)</TargetEntity><TargetEntity id="4426" type="Mechanism">Immune Checkpoint Inhibitors</TargetEntity></SourceEntity><SourceEntity id="11279" type="Action"><TargetEntity id="3690" type="Mechanism">Ubiquitin C-terminal Hydrolase 7 (USP7; HAUSP) Inhibitors</TargetEntity></SourceEntity></CrossReferences><PhaseHighest id="DR">Discovery</PhaseHighest><IndicationsPrimary><Indication id="651">Cancer</Indication></IndicationsPrimary><ActionsPrimary><Action id="11279">Ubiquitin thioesterase-7 inhibitor</Action></ActionsPrimary><ActionsSecondary><Action id="1545">Anticancer</Action></ActionsSecondary><Technologies><Technology id="762">Small molecule therapeutic</Technology></Technologies><LastModificationDate>2019-05-20T09:44:52.000Z</LastModificationDate><ChangeDateLast>2015-08-27T00:00:00.000Z</ChangeDateLast><AddedDate>2014-03-03T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;&lt;ulink linkID="19453" linkType="Company"&gt;Genentech&lt;/ulink&gt; is investigating selective USP7 inhibitors, presumably for the potential treatment of cancer [&lt;ulink linkID="1530298" linkType="Reference"&gt;1530298&lt;/ulink&gt;], [&lt;ulink linkID="1529967" linkType="Reference"&gt;1529967&lt;/ulink&gt;]. In August 2015, preclinical data were presented [&lt;ulink linkID="1682452" linkType="Reference"&gt;1682452&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary><Preclinical><displayLabel>Preclinical</displayLabel><value>&lt;Preclinical&gt;&lt;para&gt;In August 2015, preclinical data were presented at the 250th ACS meeting in Boston, MA. Deubiquitinase USP7 inhibitors showed increased potency in biochemical and cellular assays that retained USP7 selectivity.Â In addition,   inhibition by interfering with ubiquitin binding to the USP7 catalytic cleft was also achieved [&lt;ulink linkID="1682452" linkType="Reference"&gt;1682452&lt;/ulink&gt;].&lt;/para&gt;&lt;para&gt;In February 2014, preclinical data were presented at the Fourth Annual Ubiquitin Research and Drug Discovery Conference in San Diego, CA. The series of compounds demonstrated sub-micromolar activity against full-length USP7 and the catalytic domain alone. In HCT116 cells, treatment with the compounds (20 microM) resulted in  decreased Mdm2 and increased p53 and p21 levels. In a proliferation assay, a 50% decrease in proliferation was observed for the compounds at 20 microM concentrations [&lt;ulink linkID="1529967" linkType="Reference"&gt;1529967&lt;/ulink&gt;].&lt;br&gt;&lt;/br&gt;&lt;/para&gt;&lt;/Preclinical&gt;</value></Preclinical></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="19453">Genentech Inc</Company><Country id="US">US</Country><DevelopmentStatus id="DR" sortOrder="7">Discovery</DevelopmentStatus><Indication id="651">Cancer</Indication><StatusDate>2012-08-24T00:00:00.000Z</StatusDate><Source id="1530298" type="SERIAL"/></DevelopmentStatusCurrent></IDdbDevelopmentStatus><Targets><Target id="PTGT-02768"><Name>Ubiquitin thioesterase-7</Name><SwissprotNumbers><Swissprot>Q9P7S5</Swissprot><Swissprot>Q93009</Swissprot><Swissprot>P40453</Swissprot></SwissprotNumbers></Target></Targets><ReasonsForUpdate><ReasonForUpdate><Reason>Reference Added</Reason><Description>1 reference added [&lt;ulink url="utility.reference?i_reference_id=1884858" linkType="reference" linkID="1884858"&gt;1884858&lt;/ulink&gt;]							</Description></ReasonForUpdate></ReasonsForUpdate><hasSWOTs>N</hasSWOTs></drugRecordOutput>